Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00294645 · ClinicalTrials.gov registry record · NA
PREFER (Pacemaker Remote Follow-Up Evaluation and Review)
A NA study, sponsored by Medtronic Cardiac Rhythm and Heart Failure.
- Completed
- Registry status
- NA
- Development phase
- 980
- Enrollment target
NCT00294645 is a NA study that has completed, run by Medtronic Cardiac Rhythm and Heart Failure. The registered enrollment target is 980 participants.
The verdict
NCT00294645, a NA study, has completed, sponsored by Medtronic Cardiac Rhythm and Heart Failure.
- COMPLETED
- Registry status
- NA
- Development phase
- 980 participants
- Enrollment target
Study Summary
The purpose of the study is to compare remote pacemaker follow-up to current standard of care follow-up. The study will compare the rate of first diagnosis of clinically actionable events between patients who utilize the Medtronic Carelink® Network (Remote arm) versus patients who are followed via routine office visits augmented by transtelephonic monitoring (TTM)(Control arm).
Interventions
- OTHER Transtelephonic monitoring (TTM)
- OTHER Medtronic CareLink® Network
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 980 participants |
| Start Date | 2004-04 |
| Est. Completion | 2008-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00294645
The ClinicalTrials.gov registry entry for NCT00294645 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 980 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medtronic Cardiac Rhythm and Heart Failure, which has 115 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Transtelephonic monitoring (TTM) is the first listed.
NCT00294645 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00294645 about?
NCT00294645 is a clinical study titled "PREFER (Pacemaker Remote Follow-Up Evaluation and Review)". The purpose of the study is to compare remote pacemaker follow-up to current standard of care follow-up. The study will compare the rate of first diagnosis of clinically actionable events between patients who utilize the Medtronic Carelink® Network (Remote arm) versus patients who are followed via r...
What is the current status of trial NCT00294645?
This trial is currently completed. It is a NA study. The enrollment target is 980 participants. The study started on 2004-04. Estimated completion is 2008-04.
What interventions are being tested in trial NCT00294645?
The interventions under investigation include: Transtelephonic monitoring (TTM) (OTHER), Medtronic CareLink® Network (OTHER).
Who is sponsoring clinical trial NCT00294645?
This trial is sponsored by Medtronic Cardiac Rhythm and Heart Failure, which has 115 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.